Register
Adcetris + chemotherapy first-line treatment for stage III/IV classical Hodgkin lymphoma |
Journal Updates
eMediNexus Coverage from: 
Adcetris + chemotherapy first-line treatment for stage III/IV classical Hodgkin lymphoma
eMediNexus,  21 March 2018
remove_red_eye 924 Views
#Hematology #Oncology #Pathology and Lab Medicine #Pharmacist

0 Read Comments                

The US Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy. Adcetris combines an antibody and drug, allowing the antibody to direct the drug to a target on lymphoma cells known as CD30.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!